MREO (STOCKS)
Mereo BioPharma Group plc American Depositary Shares
$0.381200
-0.013900 (-3.52%)
Prev close: $0.395100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Denise Vera Scots-Knight
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $61.87M
- Employees
- 36
- P/E (TTM)
- -1.47
- P/B (TTM)
- 1.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.01 | $-0.02 | +0.0148 | +59.68% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.02 | -0.0833 | -498.80% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.01 | -0.0926 | -1,251.35% |
|
Dec 2024 (Q4)
|
$-0.05 | $-0.01 | -0.0353 | -240.07% |
Financial Statements
| Revenues | $500.00K |
| Research and Development | $22.39M |
| Operating Income/Loss | -$46.99M |
| Income/Loss From Continuing Operations After Tax | -$41.57M |
| Income/Loss From Continuing Operations Before Tax | -$41.57M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $607.00K |
| Net Income/Loss | -$41.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.06 |
| Diluted Earnings Per Share | -$0.06 |
| Basic Average Shares | 2,395,477,133 |
| Diluted Average Shares | 2,395,477,133 |
| Assets | $53.60M |
| Current Assets | $52.41M |
| Noncurrent Assets | $1.20M |
| Fixed Assets | $174.00K |
| Other Non-current Assets | $1.02M |
| Liabilities | $7.00M |
| Current Liabilities | $6.02M |
| Accounts Payable | $879.00K |
| Other Current Liabilities | $5.14M |
| Noncurrent Liabilities | $988.00K |
| Equity | $46.60M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $46.60M |
| Liabilities And Equity | $53.60M |
| Net Cash Flow From Operating Activities | -$32.71M |
| Net Cash Flow From Operating Activities, Continuing | -$32.71M |
| Net Cash Flow From Investing Activities | -$20.00K |
| Net Cash Flow From Investing Activities, Continuing | -$20.00K |
| Net Cash Flow From Financing Activities | $248.00K |
| Net Cash Flow From Financing Activities, Continuing | $248.00K |
| Exchange Gains/Losses | $657.00K |
| Net Cash Flow | -$31.82M |
| Net Cash Flow, Continuing | -$32.48M |
| Comprehensive Income/Loss | -$41.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$41.38M |
| Other Comprehensive Income/Loss | $36.40M |